06/08/2009
https://www.congress.gov...
"Our bill is the product of consultations with a wide range of stakeholders, as Senator Feinstein has mentioned, and it would give the FDA broader oversight."
"It would also give the agency the power to order companies to recall products found to be dangerous."
"See, I think that is why so many companies actually welcome our bill, because they do not want to harm consumers."
"As Senator Murray indicated, it is ironic that we have addressed and modernized the FDA in so many other areas but not in this one."